Status: current, Not sufficiently defined by necessary conditions definition status. Date: 13-Apr 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1187901000001111 | Betamethasone + Doxycycline + Nystatin | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1228851000001111 | Betamethasone + Doxycycline + Nystatin (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Betamethasone + Doxycycline + Nystatin | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Betamethasone + Doxycycline + Nystatin | Is a | Product containing betamethasone | false | Inferred relationship | Existential restriction modifier | ||
| Betamethasone + Doxycycline + Nystatin | Is a | Product containing nystatin | false | Inferred relationship | Existential restriction modifier | ||
| Betamethasone + Doxycycline + Nystatin | Is a | Product containing doxycycline | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Betamethasone 0.05% / Doxycycline 10% / Nystatin 2% powder for mouthwash sachets sugar free | Is a | True | Betamethasone + Doxycycline + Nystatin | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR